Imperial Oil Limited (IMO)
AMEX: IMO
· Real-Time Price · USD
81.43
0.45 (0.56%)
At close: Jul 03, 2025, 2:00 PM
81.20
-0.28%
After-hours: Jul 03, 2025, 04:58 PM EDT
Imperial Oil Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2022 | Dec 31, 2020 | Dec 31, 2018 |
|---|---|---|---|---|
| Chemical Revenue | 1.45B | 3.95B | 1.01B | 1.52B |
| Chemical Revenue Growth | -63.34% | +292.06% | -33.60% | n/a |
| Downstream Revenue | 56.94B | 129.93B | 16.74B | 26.84B |
| Downstream Revenue Growth | -56.17% | +676.33% | -37.64% | n/a |
| Upstream Revenue | 18.02B | 39.39B | 8.8B | 11.17B |
| Upstream Revenue Growth | -54.27% | +347.80% | -21.24% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 |
|---|---|---|---|---|---|---|---|---|---|
| United States Revenue | 10.3B | 12.39B | 7.23B | 4.61B | 7.19B | 4.39B | 3.61B | 4.16B | 5.94B |
| United States Revenue Growth | -16.90% | +71.47% | +56.65% | -35.83% | +63.71% | +21.59% | -13.11% | -30.02% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | 255M | 224M | 221M | 247M | 250M | 257M | 226M | 206M | 261M | 209M | 191M | 225M | 215M | 180M | 200M | 189M | 242M | 150M | 183M | 166M | 234M | 217M | 236M | 213M | 217M | 224M | 273M | 194M | 267M | 219M | 201M | 206M | 317M | 275M | 267M | 270M | 314M | 267M | 272M | 264M |
| Selling, General, and Administrative Revenue Growth | -100.00% | +13.84% | +1.36% | -10.53% | -1.20% | -2.72% | +13.72% | +9.71% | -21.07% | +24.88% | +9.42% | -15.11% | +4.65% | +19.44% | -10.00% | +5.82% | -21.90% | +61.33% | -18.03% | +10.24% | -29.06% | +7.83% | -8.05% | +10.80% | -1.84% | -3.12% | -17.95% | +40.72% | -27.34% | +21.92% | +8.96% | -2.43% | -35.02% | +15.27% | +3.00% | -1.11% | -14.01% | +17.60% | -1.84% | +3.03% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | 84M | n/a | n/a | n/a | 74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |